<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ten <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>- and two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-patients in whom conventional chemotherapy was contraindicated or ineffective were treated with low dose ARA-C, 10 mg/m2 per 12hS.C. for 2-4 weeks </plain></SENT>
<SENT sid="1" pm="."><plain>Seven patients obtained a complete and two a partial remission </plain></SENT>
<SENT sid="2" pm="."><plain>Our findings suggest that low dose ARA-C may act both by induction of differentiation and/or inhibition of proliferation </plain></SENT>
</text></document>